377 results about "Hypopigmentation" patented technology

The application of matrix metalloproteinase (MMP) inhibitors to the skin inhibits the degradation of proteins found in the skin including collagen, elastin, and other basement membrane and extracellular matrix protein. MMP inhibitors may be used in both cosmetic compositions and pharmaceutical compositions for application to skin. MMP inhibitors are formulated with a cosmetically suitable vehicle or pharmaceutically acceptable excipient for application to the skin as creams, lotions, ointments, solutions, face masks, etc. As cosmetics, the inventive MMP inhibitor compositions are applied to the skin to prevent or reduce the appearance of wrinkles, pigmentation changes, loss of elasticity, or other effects associated with aging or sun damage. As pharmaceuticals, the inventive MMP inhibitor compositions may also be applied to the skin to treat or prevent a skin disease (e.g., proliferative disease, inflammatory disease).

The evolution of a skin condition over time can be useful in its assessment. In an illustrative arrangement, a user captures skin images at different times, using a smartphone. The images are co-registered, color-corrected, and presented to the user (or a clinician) for review, e.g., in a temporal sequence, or as one image presented as a ghosted overlay atop another. Image registration can employ nevi, hair follicles, wrinkles, pores, and pigmented regions as keypoints. With some imaging spectra, keypoints from below the outermost layer of skin can be used. Hair may be removed for image registration, and restored for image review. Transformations in addition to rotation and affine transforms can be employed. Diagnostic correlations with reference image sequences can be made, employing machine learning in some instances. A great variety of other features and arrangements are also detailed.

This invention provides a relatively fast and safe method of producing a permanent or nearly permanent skin image, design, or tattoo similar in appearance to that of a solar tattoo. A protective design template is placed on the skin and a cryogenic agent applied to freeze exposed portions of the skin, producing hypopigmentation. An image is defined by the contrast between the treated (hypopigmented) skin and the adjacent untreated skin.

The present invention provides a composition comprising an effective amount of benfotiamine and an effective amount of pyridoxamine in a suitable vehicle for topical application. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles, loss of elasticity, and hyperpigmentation caused by chronoaging and / or photoaging of skin, by inhibiting particularly skin damage resulting from reactive carbonyl species (RCS), glycation of skin proteins, formation of advanced glycation endproducts (AGEs) and formation of advanced lipoxidation endproducts (ALEs).

The invention provides unique and novel strains of microalgae that have been subjected to non-transgenic methods of mutation sufficient to reduce the coloration of biomass produced by the strains. Biomass produced from such strains can be used in the manufacture of baked goods, gluten free foods, beverages, high lipid algal flours, and other foods. Pigments such as carotenoids and chlorophyll can be undesirable for consumer acceptance when incorporated into foods such as mayonnaise, yogurt, and white sauces that are not traditionally associated with colors such as yellow, red, orange and green. Some pigments, such as chlorophyll, can also create undesirable taste profiles. Use of reduced pigment microalgal biomass expands the range of food products that can be manufactured with healthy lipid profiles. High protein containing biomass of the invention, also reduced in pigmentation, is also incorporated into products such as meat analogues, nutritional bars and meal replacement beverages. The reduced pigmentation microalgae also allow for incorporation of higher amounts of biomass into certain food products that could otherwise be achieved using highly pigmented microalgal biomass. Methods of generating novel reduced pigment microalgae are disclosed herein. The strains provided by the invention are also useful in the manufacture of healthy, neutral colored extracted triglyceride oils.

The present invention concerns methods and compositions that can be used, for example, in skin whitening or hyperpigmentation applications. The composition, in non-limiting aspects, can include a vitamin C derivative, niacinamide, an extract formulation comprising cucumber and lemon extract or compounds that include the following formulas: where R1, R2, R3, R4, and R5 are independently an H, an alkyl group, a hydroxyalkyl group, or a carboxyalkyl group where R1, R2, R3, R4, and R5 are independently an H, an alkyl group, a hydroxyalkyl group, or a carboxyalkyl group and where x is an integer from 1 to 30.

The present invention describes systems and methods for treating disorders and / or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and / or actinic keratosis. Methods generally involve administering nanoemulsions (e.g., nanoparticle compositions) comprising at least one therapeutic agent, such as botulinum toxin. In some embodiments, nanoemulsions are prepared, e.g., by high pressure microfluidization, and comprise a particle size distribution exclusively between 10 nm and 300 nm.

The present invention describes systems and methods for treating disorders and / or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and / or actinic keratosis. Methods generally involve administering nanoemulsions (e.g., nanoparticle compositions) comprising at least one therapeutic agent, such as botulinum toxin. In some embodiments, nanoemulsions are prepared, e.g., by high pressure microfluidization, and comprise a particle size distribution exclusively between 10 nm and 300 nm.

The invention relates to an intermedin analogue prepared by bonding a ring core sequence with biotin or cell-penetrating peptides and a preparation method and application of the intermedin analogue. The intermedin analogue is prepared by bonding a functional unit with the biotin or a load unit; the functional unit is a seven-peptide structure formed by connecting the ring core sequence c (Asp-Dab-D-Phe-Arg-Trp-Lys) with a connection unit Arg, the structure is Arg-c (Asp-Dab-D-Phe-Arg-Trp-Lys); the load unit is the 48th-57th peptide segments Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg or the 55th-57th peptide segments Arg-Arg-Arg in the 47th-60th segments of HIV (human immunodeficiency virus)-1TAT protein. The intermedin analogue disclosed by the invention can penetrate through mucosa or skin to be absorbed, and can be applied to treatment of diseases such as male and female sexual dysfunction, obesity, pigmentation deficiency and the like.

A composition is provided to treat and / or prevent for treating skin conditions including fine lines and wrinkles, acne rosacea, surface irregularities of the skin and hyper-pigmentation melasma of the skin, which includes use of a topically applied composition such as an ointment, lotion, cream, serum, gel or pad applied formulation, containing an effective amount of polyphenols, such as green tea based polyphenols, including but not limited to catechins, such as epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicathechin 3-gallate (ECG) and epicatechin (EC). The formulation is preferably composed of 90 percent polyphenol isolates, derived from green tea with potent antioxidant properties, to assist in minimizing free-radical induced skin damage.

The present invention generally relates to improved medical devices, systems, and methods, with exemplary embodiments providing improved cooling treatment probes and cooling treatment methods and systems. In some embodiments, freezing of the skin may be desirable to effect the hypopigmentation of the skin of the patient. Generally, embodiments may limit supercooling of the skin of the patient during a cooling treatment. Additionally, embodiments may limit adverse side effects such as hyperpigmentation. It has been found that the freezing behavior (frequency and time to freeze) can be modified by adjusting the thermal parameters of the cooling applicator. Accordingly, in some aspects of the invention, a method of treating the skin may be provided where the thermal parameters of the cooling applicator are adjusted during treatment.

In recognition of the need to develop novel therapeutic agents, the present invention provides novel histone deacetylase inhibitors. These compounds include an ester bond making them sensitive to deactivation by esterases. Therefore, these compounds are particularly useful in the treatment of skin disorders. When the compounds reaches the bloodstream, an esterase or an enzyme with esterase activity cleaves the compound into biologically inactive fragments or fragments with greatly reduced activity Ideally these degradation products exhibit a short serum and / or systemic half-life and are eliminated rapidly. These compounds and pharmaceutical compositions thereof are particularly useful in treating cutaneous T-cell lymphoma, neurofibromatosis, psoriasis, hair loss, skin pigmentation, and dermatitis, for example. The present invention also provides methods for preparing compounds of the invention and intermediates thereto.

This invention relates to methods and compositions for treating and ameliorating skin conditions including post inflammatory hyperpigmentation (PIH) More particularly, this invention relates to compositions containing certain natural extracts, salicylic acid, and natural or synthetic retinoids. The composition was clinically proven to reduce PIH.

The invention discloses a rhodiola crenulata facial mask with whitening and moisturizing effects. The rhodiola crenulata facial mask is mainly prepared from rhodiola crenulata root extract, black tea extract, blueberry fruit extract, hydrolyzed silk and corresponding adjuvants. Rhodiola crenulata can nourish and moisturize skin and keep constant moisture and elasticity of the skin, has anti-oxidation and whitening functions and is called 'gold plant' in the Compendium of Materia Medica. Blueberry is honored as a 'skin cosmetic taken orally' and rich in anthocyanin which is a purely natural anti-aging nutrition supplement. Black tea can moisturize skin, promote blood circulation and activate cells, and also has antibacterial and refreshing functions and the like. The rhodiola crenulata body lotion, prepared from rhodiola crenulata serving as 'monarch', blueberry serving as 'minister' and black tea serving as 'assistant', can promote skin metabolism, enhance activity, reduce epidermal pigmentation, resist against oxidation and remove oxygen free radicals; and the rhodiola crenulata facial mask is fine and smooth, deeply moisturizes the skin, and enables skin to keep moist, soft, smooth and glossy for a long time.

The present invention provides compositions containing one or more calcium sequestration agents and methods for topical application of such compositions to the skin to treat skin pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation, pigmentation changes due to skin aging, or any other skin conditions related with normal such as skin of color or abnormal pigmentation such as hypo- or hyper-pigmentation in humans.

Sets of genes are identified that show modulated activity in hyperpigmented sun-exposed (HE) and non-hyperpigmented sun-exposed (NHE) skin, when compared to non-hyperpigmented non-exposed (NHNE) skin. The modulated sets of genes reveal important information about the genetic changes that take place in skin as a result of environmental exposure and damage. The modulated sets of genes may be used to fabricate custom DNA microarrays for evaluating patients with skin diseases or disorders. The microarrays may also be used to screen new substances for treating skin diseases and disorders. The modulated gene sets, and substances that target them, may also be used to develop therapies for individuals who suffer from hypopigmentation, such as those with Fitzpatrick type I skin or vitiligo.

The invention relates to a novel tyramine derivate and a method for preparing the compound. The invention also relates to a cosmetic or medical skin composition having the compound, as well as the application of the compound in the skin care field, in particular to the application in order to release the over-pigmentation.

The invention discloses a medicinal ointment for treating burns, wherein the active constituents mainly compirse alkanna tinctoria, baikal skullcap root, goldthread root, corktree bark, rhubarb horsetails, giant knotweed rhizome, bletilla striata, root of red rooted saliva, garden burnet root and auxiliary materials including excipient and sesame oil.

The invention discloses application of glacial water in preparation of an externally applied agent for the skin and a glacial water-containing externally applied agent for the skin. It is found for the first time that glacial water can obviously promote propagation of fibroblasts, improve synthesis of fibroblast collagen I and elastin laminin of the skin and substantially inhibit propagation activity of human epidermal melanocytes (HEM-m) and formation of melanin. Glacial water is used as one or more selected from the group consisting of an anti-aging active component, a whitening active component and a moisture-retaining component of the externally applied agent for the skin; so the glacial water-containing externally applied agent for the skin is natural and safe and is capable of improving skin elasticity, resisting crease, repairing impaired skin, reducing hyperpigmentation and whitening the skin.

Compositions for treating skin containing at least one extract from the genus Trametes and at least one viscosity enhancing synthetic polymer, and methods for whitening skin, treating skin for improvement, or treating skin disorders associated with pigmentation such as uneven pigmentation, skin mottling, or age spots or other dermatological disorders such as eczema, rosacea, hyperkeratinization, and so on.

The invention discloses a rhodiola crenulata eye cream with whitening and anti-wrinkle effects. The rhodiola crenulata eye cream is mainly prepared from rhodiola crenulata root extract, black tea extract, coix seed extract, honeysuckle flower extract and corresponding adjuvants. Rhodiola crenulata can nourish and moisturize skin and keep constant moisture and elasticity of the skin and has anti-oxidation and whitening functions. Known from Compendium of Materia Medica, coix seeds have the functions of 'nourishing facial appearance and keeping youth', whitening and removing freckles, contracting pores, excreting water and slimming bodies. Black tea can moisturize skin, promote blood circulation and activate cells. Honeysuckle flower, also named lonicera japonica, can improve the water keeping capability of the skin and form a natural water keeping screen. The rhodiola crenulata eye cream is prepared from rhodiola crenulata serving as 'monarch', coix seeds serving as 'minister', black tea serving as 'assistant' and honeysuckle flower serving as 'guide' under the support of adjuvants. The rhodiola crenulata eye cream can promote skin metabolism, enhance skin activity, reduce epidermal pigmentation and resist against oxidation and removing oxygen free radicals; and the rhodiola crenulata eye cream is fine and smooth, has certain whitening, moisturizing and anti-wrinkle effects andprevents generation of thin wrinkles near eyes.

Embodiments of the present invention generally relate to methods, devices, and systems for reducing a pigmentation of a skin of a patient. In some embodiments, freezing of the skin may be desirable to effect the hypopigmentation of the skin of the patient. Generally, embodiments may limit supercooling (or promote freezing) of the skin of the patient during a cooling treatment. In some embodiments, coupling fluids are provided to reduce a thermal contact resistance between a cooling treatment probe and the skin of the patient to improve cooling treatment. Optionally, a fluid carrier may be provided to help retain the coupling fluid at the treatment site. In some embodiments, the coupling fluid may include ice nucleating agents to promote ice crystal formation in the coupling fluid during cooling treatment. The ice crystal formation in the coupling fluid may progress into the skin to limit supercooling of the skin during treatment.

The invention discloses whitening and spot eliminating cream and a preparation method thereof. The whitening and spot eliminating cream comprises an active ingredient and auxiliary materials, whereinthe active ingredient is a extracting solution of traditional Chinese medicine, and the traditional Chinese medicine comprises the following materials in percentage by weight: 5%-55% of conic gymnadenia rhizome, 15%-35% of ginseng flower, 5%-15% of flos albiziae, 5%-15% of honeysuckle, 15%-20% of flos rosae rugosae and 5%-10% of chrysanthemum. The whitening spot eliminating cream can restrain thegeneration of melanin, also has the functions of activating blood and dissolving stasis, clearing away heat and toxic materials, achieves the comprehensively regulated whitening and spot eliminating effect and is convenient to use; in addition, the whitening spot eliminating cream adds nanoscale titanium pigment to achieve instant whitening effect and can solve skin problems, i.e. chloasmata, butterfly spots, age pigments, and the like which are caused by chromatosis after being continuously used for 28 days.

This invention provides a method of preventing or treating in a subject contact dermatitis which comprises administering to the subject an amount of a compound capable of inhibiting the stem cell factor signaling pathway effective to prevent or treat contact dermatitis so as to thereby prevent or treat contact dermatitis in the subject. This invention also provides a method of preventing or treating in a subject hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception.

The invention discloses a quercetin skin lipidosome and lyophilized powder thereof, belongs to the technical field of medicines, and aims to solve the problems that the quercetin is poor in solubility and difficult to apply, improve the penetration amount and the penetration rate of quercetin into a corneum and enhance the retention of a medicine in an epidermis and a dermis so as to play the efficacy better. Every 100 mL of lipidosome solution is prepared from the following substances: 0.01-0.1g of quercetin, 0.1-1.2g of amphiphilic lipid, 0.025-0.6g of cholesterol, 0.05-3g of surfactant, 0.001-0.5g of antioxidant and the balance of aqueous medium. The quercetin skin lipidosome and the lyophilized powder thereof are external preparations for a skin, and are applicable to oxidation resistance, inflammation resistance, ultraviolet radiation damage resistance, skin cancer resistance, and resistance to edema, red spots, pigmentation, inflammation and immune suppression which are caused by ultraviolet radiation.

Exemplary embodiments of the present disclosure provide method and apparatus for effecting (e.g., lightening) an appearance of skin by cooling or freezing small separated surface regions of the skin to produce regions of local hypopigmentation. The width of the regions can be, for example, smaller than about 1 mm or 0.5 mm, and a distance between these frozen regions can be greater than about 3 times the width of the regions. An exemplary apparatus can be provided that includes a plurality of spatially-separated thermally conductive arrangements that can be affixed or otherwise coupled to a base. For example, the conductive arrangements can be regions of conductive material provided in or proximal to a thermal insulator, or thermally conductive protrusions affixed to the base.; The conductive arrangements can be cooled and then contacted with the skin surface to produce the small regions of hypopigmentation.

The present invention relates generally to nucleic acid sequences encoding flavonoid 3'-hydroxylase (hereinafter referred to as "F3'H") and their use in the manipulation of pigmentation in flowers of plants.